['pulmonary embolism', 'thromboembolism', 'thrombosis', 'venous thrombosis', 'venous thromboembolism']
['bay 59-7939', 'bay 59-7939', 'asa']

        Inclusion Criteria:

          -  Patients with confirmed symptomatic PE and/or DVT who have been treated for 6 to 12
             months and did not interrupt anticoagulation for longer than 1 week

        Exclusion Criteria:

          -  Legal lower age limitations (country specific) Indication for therapeutic-dosed
             anticoagulants Indication for antiplatelet therapy or a conventional non-steroid
             anti-inflammatory drug (NSAID) Hepatic disease which is associated with coagulopathy
             leading to a clinically relevant bleeding risk Calculated creatinine clearance < 30
             mL/min
      